查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1331133

螺蟲乙酯全球市場

Spirotetramat
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，螺蟲乙酯全球市場將達到 3.067 億美元

在不斷變化的後COVID-19商業環境中，螺蟲乙酯的全球市場預計2022年為2.122億美元，預計到2030年將達到3.067億美元，從2022年到2030年不斷成長。預計年複合成長率同比成長 4.7%。

美國市場估計為5640萬美元，中國預計年複合成長率為7.1%

2022年美國螺蟲乙酯市場估計為5640萬美元。中國作為世界第二大經濟體，預計在2022年至2030年的分析期間將以7.1%的年複合成長率成長，2030年市場規模將達到6680萬美元。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 2.9% 和 3.8%。在歐洲，德國預計年複合成長率約為 3.7%。

受訪企業示例

  • Bayer CropScience

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳大利亞
  • 印度
  • 韓國
  • 亞太地區其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競爭

簡介目錄
Product Code: MCP16046

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Spirotetramat Market to Reach $306.7 Million by 2030

In the changed post COVID-19 business landscape, the global market for Spirotetramat estimated at US$212.2 Million in the year 2022, is projected to reach a revised size of US$306.7 Million by 2030, growing at a CAGR of 4.7% over the period 2022-2030.

The U.S. Market is Estimated at $56.4 Million, While China is Forecast to Grow at 7.1% CAGR

The Spirotetramat market in the U.S. is estimated at US$56.4 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$66.8 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 3.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Select Competitors (Total 46 Featured) -

  • Bayer CropScience

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Spirotetramat - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Spirotetramat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Spirotetramat Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • JAPAN
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • CHINA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • EUROPE
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Spirotetramat by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • GERMANY
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • UNITED KINGDOM
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • ASIA-PACIFIC
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Spirotetramat by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • AUSTRALIA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • INDIA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • LATIN AMERICA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Spirotetramat by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • MIDDLE EAST
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Spirotetramat by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • AFRICA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

IV. COMPETITION